Recommend Epigenetics to your librarian today. Download form here.
Sign up for Table of Contents Alerts.
The official journal of the Epigenetics Society.
Email this page
Print this page
Research Paper
Identification of DNA Methylation in 3' Genomic Regions that are Associated with Upregulation of Gene Expression in Colorectal Cancer
Joseph F. Smith, Saleh Mahmood, Fei Song, Arlene Morrow, Dominic Smiraglia, Xueli Zhang, Ashwani Rajput, Michael J. Higgins, Anton Krumm, Nicholas J. Petrelli, Joseph F. Costello, Hiroki Nagase, Christoph Plass and William Held
volume 2 | issue 3
july/august/september 2007Subscribe to this journal for $79/year
Restriction Landmark Genomic Scanning (RLGS), a method for the two-dimensional display of end-labeled DNA restriction fragments, was utilized to identify genomic regions of CpG island methylation associated with Human Colon Cancer. An Average of 1.5% of the RLGS loci/spots are lost or significantly reduced in sporadic primary colon tumors relative to normal colon mucosa from the same patient. This may represent tumor specific methylation of about 400 CpG islands in sporadic colon cancer. A number of RLGS loci exhibiting frequent loss associated with colon cancer were cloned. DNA sequence analysis indicated that the RLGS loci identified genomic regions characteristic of CpG islands. A number of methods including bisulfite genomic sequencing as well as quantitative MassARRAY methylation analysis (www.sequenom.com) confirmed tumor specific methylation at several of these loci. DNA database searches indicated that candidate genes associated with these loci include transcription factors and genes involved in signal transduction (52%), and genes of unknown function (37%). Expression analysis using quantitative real time RT-PCR indicates that methylation of some CpG islands located in non-promoter regions were associated with up-regulation of gene expression in colorectal cancer. These results indicate that alterations in methylation status within CpG islands in colon tumors may have complex consequences on gene expression and tumorigenesis, sometimes resulting in up regulation or ectopic gene expression that may involve novel regulatory mechanisms.
Authors
Joseph F. Smith
Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, New York USA
Saleh Mahmood
Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, New York USA
Fei Song
Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, New York USA
Arlene Morrow
Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, New York USA
Dominic Smiraglia
Department of Cancer Genetics; Roswell Park Cancer Institute, Buffalo, New York USA
Xueli Zhang
Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, New York USA
Ashwani Rajput
GI Surgery; Roswell Park Cancer Institute, Buffalo, New York USA
Michael J. Higgins
Department of Cancer Genetics; Roswell Park Cancer Institute; Buffalo, New York USA
Anton Krumm
Department of Radiation Oncology; University of Washington School of Medicine; Seattle, Washington USA
Nicholas J. Petrelli
Helen F. Graham Cancer Center at Christiana Care; Newark, Delaware, USA
Joseph F. Costello
CBT Editorial Board Department of Neurological Surgery; Comprehensive Cancer Center; University of California; San Francisco, California USA
Hiroki Nagase
Department of Cancer Genetics; Roswell Park Cancer Institute; Buffalo, New York USA
Christoph Plass
Division of Human Cancer Genetics; Department of Molecular Virology Immunology and Medical Genetics; Ohio State University; Columbus, Ohio USA
William Held
Department of Molecular and Cellular Biology; Roswell Park Cancer Institute; Buffalo, New York, USA





